Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Larsbjørnsstræde 8 is a Danish holding company and investment vehicle primarily associated with Lars Wismann, a prominent figure in the Danish business and biotech investment community. While the company's primary registered activity is the rental and operation of commercial real estate in Copenhagen, it is notably used as a vehicle for shareholder activism and strategic investments in the life sciences sector. The entity is frequently cited in corporate governance contexts, particularly regarding its involvement as a shareholder in major Danish biotech firms such as Bavarian Nordic. Through this and related entities, Lars Wismann engages in critical analysis and advocacy concerning corporate leadership and strategic direction within the pharmaceutical and vaccine industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Larsbjørnsstræde 8.